These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9578086)

  • 41. [Utility of the paraffin-embedded section method on the detection of estrogen receptor from breast cancer tissues--comparison of the paraffin-embedded section method (6F11 and 1D5) with frozen section (H222) and dextran-coated charcoal (DCC) ones].
    Kawabata K; Watanabe K; Ozaki S; Ishiyama S
    Rinsho Byori; 1999 Aug; 47(8):767-73. PubMed ID: 10511809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of monoclonal antibodies in immunocytochemical localization of estrogen receptors in ovarian cancer.
    Masood S
    Cancer Detect Prev; 1988; 12(1-6):283-90. PubMed ID: 3052833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Analysis of estrogen receptors in mammary carcinomas. Is immunocytochemical determination after formalin fixation sufficient?].
    Haugen OA; Aasmundstad T; Johannesen E; Ytterhus B; Nervik I
    Tidsskr Nor Laegeforen; 1993 Mar; 113(8):944-6. PubMed ID: 8470071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry.
    Hsu FD; Nielsen TO; Alkushi A; Dupuis B; Huntsman D; Liu CL; van de Rijn M; Gilks CB
    Mod Pathol; 2002 Dec; 15(12):1374-80. PubMed ID: 12481020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody-recognized [125I]estradiol-receptor complex in ovarian epithelial carcinoma.
    Holt JA; Lorincz MA; King WJ
    Obstet Gynecol; 1983 Aug; 62(2):231-5. PubMed ID: 6866366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcome.
    Francis G; Beadle G; Thomas S; Mengersen K; Stein S
    Pathology; 2006 Oct; 38(5):391-8. PubMed ID: 17008275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
    Vang R; Gown AM; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM
    Am J Surg Pathol; 2006 Sep; 30(9):1130-9. PubMed ID: 16931958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays.
    Press MF; Holt JA; Herbst AL; Greene GL
    Lab Invest; 1985 Sep; 53(3):349-61. PubMed ID: 4033069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HAM56 antibody: a tool in the differential diagnosis between colorectal and gynecological malignancy.
    Younes M; Katikaneni PR; Lechago LV; Lechago J
    Mod Pathol; 1994 Apr; 7(3):396-400. PubMed ID: 8058715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer.
    Rocha RM; Nunes CB; Sanches FS; Rocha GF; Oliveira FN; Reis-Filho JS; Lambros MB; Gobbi H
    Rev Assoc Med Bras (1992); 2009; 55(2):163-8. PubMed ID: 19488652
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of anti-estrogen receptor antibodies SP1, 6F11, and 1D5 in breast cancer: lower 1D5 sensitivity but questionable clinical implications.
    Bogina G; Zamboni G; Sapino A; Bortesi L; Marconi M; Lunardi G; Coati F; Massocco A; Molinaro L; Pegoraro C; Venturini M
    Am J Clin Pathol; 2012 Nov; 138(5):697-702. PubMed ID: 23086770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
    Gomez-Fernandez C; Mejias A; Walker G; Nadji M
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):137-41. PubMed ID: 19875957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progesterone receptor detection in paraffin sections of human breast cancers by an immunoperoxidase technique incorporating microwave heating.
    Goldberg DE; Stuart J; Koerner FC
    Mod Pathol; 1994 Apr; 7(3):401-6. PubMed ID: 8058716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of estrogen receptors in breast cancer detected by various methods: lack of correlation].
    Barbareschi M; Losi L; Capitanio G; Dittadi R; Gion M; Ludvìkovà M; Fina P; Dalla Palma P; Eusebi V
    Pathologica; 1997 Aug; 89(4):397-404. PubMed ID: 9471608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The utility of estrogen receptor and progesterone receptor immunohistochemistry in the distinction of metastatic breast carcinoma from other tumors in the liver.
    Nash JW; Morrison C; Frankel WL
    Arch Pathol Lab Med; 2003 Dec; 127(12):1591-5. PubMed ID: 14632573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1D5 and 6F11: An immunohistochemical comparison of two monoclonal antibodies for the evaluation of estrogen receptor status in primary breast carcinoma.
    Kaplan PA; Frazier SR; Loy TS; Diaz-Arias AA; Bradley K; Bickel JT
    Am J Clin Pathol; 2005 Feb; 123(2):276-80. PubMed ID: 15842054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Immunohistochemistry in pathology of the breast. Current diagnostic and prognostic contributions].
    Le Doussal V; Champy O; Le Ray C
    Arch Anat Cytol Pathol; 1994; 42(5):269-84. PubMed ID: 7532935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Toward the use of monoclonal antibodies in the analysis of tumor progression and cellular heterogeneity of human breast cancer.
    Nilsson K
    Acta Chir Scand Suppl; 1984; 519():15-8. PubMed ID: 6595923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.